CytoDyn (CYDY) Income from Continuing Operations (2009 - 2026)
CytoDyn (CYDY) recorded Income from Continuing Operations of -$19.94 million in fiscal Q1 2027 (quarter ended Aug 31, 2026), compared with -$5.54 million a year earlier.
Powered by 
Analysis
CytoDyn (CYDY) Income from Continuing Operations (2009 - 2026) Analysis & Trends
On a TTM basis, CytoDyn's Income from Continuing Operations came in at -$57.1 million as of Aug 31, 2026; for FY2026 (ended May 31, 2026), it came in at -$42.7 million.
- Across earlier fiscal years, Income from Continuing Operations came in at $3.75 million in FY2025, -$49.84 million in FY2024, -$79.82 million in FY2023 and -$210.82 million in FY2022.
- Quarterly Income from Continuing Operations has ranged from -$84.12 million in fiscal Q4 2022 to $19.23 million in fiscal Q1 2025 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$9.86 million (Q4 2026), -$4.69 million (Q3 2026) and -$22.61 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.80 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | CytoDyn | 334.50 Mn | 285.65 Mn | - | -19.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | -19.94 Mn |
| May 31, 2026 | -9.86 Mn |
| Feb 28, 2026 | -4.69 Mn |
| Nov 30, 2025 | -22.61 Mn |
| Aug 31, 2025 | -5.54 Mn |
| May 31, 2025 | -5.96 Mn |
| Feb 28, 2025 | -4.76 Mn |
| Nov 30, 2024 | -4.77 Mn |
| Aug 31, 2024 | 19.23 Mn |
| May 31, 2024 | -16.79 Mn |
| Feb 29, 2024 | -11.92 Mn |
| Nov 30, 2023 | -9.56 Mn |
| Aug 31, 2023 | -11.57 Mn |
| May 31, 2023 | -18.64 Mn |
| Feb 28, 2023 | -13.70 Mn |
| Nov 30, 2022 | -26.50 Mn |
| Aug 31, 2022 | -20.99 Mn |
| May 31, 2022 | -84.12 Mn |
| Feb 28, 2022 | -41.29 Mn |
| Nov 30, 2021 | -40.08 Mn |
API Access
CytoDyn Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CYDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "CYDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=CYDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();